1-17 of 17
Aliana Guerrieri-Gonzaga
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fenretinide in Young Women at Genetic or Familial Risk of Breast Cancer: A Placebo-Controlled Biomarker Trial

Valentina Aristarco, Davide Serrano, Patrick Maisonneuve, Aliana Guerrieri-Gonzaga, Matteo Lazzeroni, Irene Feroce, Debora Macis, Elena Cavadini, Elena Albertazzi, Costantino Jemos, Emanuela Omodeo Salè, Laura Cortesi, Samuele Massarut, Marcella Gulisano, Maria Grazia Daidone, Harriet Johansson, Bernardo Bonanni
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2024) 17 (6): 255–263.
https://doi.org/10.1158/1940-6207.CAPR-23-0422
Published: 04 June 2024
View articletitled, Fenretinide in Young Women at Genetic or Familial Risk of Breast Cancer: A Placebo-Controlled Biomarker Trial
Open the PDF for Fenretinide in Young Women at Genetic or Familial Risk of Breast Cancer: A Placebo-Controlled Biomarker Trial in another window
Journal Articles

Abstract PR004: Radiogenomics for predicting underestimation of invasiveness in ductal carcinoma in situ (DCIS) diagnosed with vacuum assisted breast biopsy: study rationale and design

Matteo Lazzeroni, Luca Nicosia, Elena Guerini Rocco, Sara Gandini, Sara Raimondi, Massimo Barberis, Nicola Fusco, Marta Cremonesi, Daniela Origgi, Enrico Cassano, Aliana Guerrieri Gonzaga, Davide Serrano, Debora Macis, Harriet Johansson, Bernardo Bonanni
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2022) 15 (12_Supplement_1): PR004.
https://doi.org/10.1158/1940-6215.DCIS22-PR004
Published: 01 December 2022
View articletitled, Abstract PR004: Radiogenomics for predicting underestimation of invasiveness in ductal carcinoma in situ (DCIS) diagnosed with vacuum assisted breast biopsy: study rationale and design
Journal Articles

Quality of Life in a Randomized Breast Cancer Prevention Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal Women

Davide Serrano, Sara Gandini, Aliana Guerrieri-Gonzaga, Irene Feroce, Harriet Johansson, Debora Macis, Valentina Aristarco, Bernardo Bonanni, Andrea DeCensi
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2018) 11 (12): 811–818.
https://doi.org/10.1158/1940-6207.CAPR-18-0073
Published: 10 December 2018
View articletitled, Quality of Life in a Randomized Breast Cancer Prevention Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal Women
Open the PDF for Quality of Life in a Randomized Breast Cancer Prevention Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal Women in another window
Journal Articles

A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast Cancer

Matteo Lazzeroni, Aliana Guerrieri-Gonzaga, Sara Gandini, Harriet Johansson, Davide Serrano, Massimiliano Cazzaniga, Valentina Aristarco, Debora Macis, Serena Mora, Pietro Caldarella, Gianmatteo Pagani, Giancarlo Pruneri, Antonella Riva, Giovanna Petrangolini, Paolo Morazzoni, Andrea DeCensi, Bernardo Bonanni
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2017) 10 (6): 363–370.
https://doi.org/10.1158/1940-6207.CAPR-16-0298
Published: 01 June 2017
View articletitled, A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast Cancer
Open the PDF for A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast Cancer in another window
Journal Articles

A Randomized, Placebo-Controlled, Phase II, Presurgical Biomarker Trial of Celecoxib Versus Exemestane in Postmenopausal Breast Cancer Patients

Valentina Aristarco, Davide Serrano, Sara Gandini, Harriet Johansson, Debora Macis, Aliana Guerrieri-Gonzaga, Matteo Lazzeroni, Irene Feroce, Giancarlo Pruneri, Gianmatteo Pagani, Antonio Toesca, Pietro Caldarella, Andrea DeCensi, Bernardo Bonanni
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2016) 9 (5): 349–356.
https://doi.org/10.1158/1940-6207.CAPR-15-0311
Published: 01 May 2016
View articletitled, A Randomized, Placebo-Controlled, Phase II, Presurgical Biomarker Trial of Celecoxib Versus Exemestane in Postmenopausal Breast Cancer Patients
Open the PDF for A Randomized, Placebo-Controlled, Phase II, Presurgical Biomarker Trial of Celecoxib Versus Exemestane in Postmenopausal Breast Cancer Patients in another window
Journal Articles

A Presurgical Study of Oral Silybin-Phosphatidylcholine in Patients with Early Breast Cancer

Matteo Lazzeroni, Aliana Guerrieri-Gonzaga, Sara Gandini, Harriet Johansson, Davide Serrano, Massimiliano Cazzaniga, Valentina Aristarco, Antonella Puccio, Serena Mora, Pietro Caldarella, Gianmatteo Pagani, Giancarlo Pruneri, Antonella Riva, Giovanna Petrangolini, Paolo Morazzoni, Andrea DeCensi, Bernardo Bonanni
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2016) 9 (1): 89–95.
https://doi.org/10.1158/1940-6207.CAPR-15-0123
Published: 06 January 2016
View articletitled, A Presurgical Study of Oral Silybin-Phosphatidylcholine in Patients with Early Breast Cancer
Open the PDF for A Presurgical Study of Oral Silybin-Phosphatidylcholine in Patients with Early Breast Cancer in another window
Journal Articles

Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial

Andrea DeCensi, Matteo Puntoni, Aliana Guerrieri-Gonzaga, Massimiliano Cazzaniga, Davide Serrano, Matteo Lazzeroni, Andrea Vingiani, Oreste Gentilini, Marilena Petrera, Giuseppe Viale, Jack Cuzick, Bernardo Bonanni, Giancarlo Pruneri
Journal: Cancer Prevention Research
Series: Author Choice
Cancer Prev Res (Phila) (2015) 8 (10): 888–894.
https://doi.org/10.1158/1940-6207.CAPR-15-0048
Published: 04 October 2015
View articletitled, Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial
Open the PDF for Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial in another window
Includes: Supplementary data
Journal Articles

Abstract A71: 4-HPR trial: A new phase III chemoprevention trial with fenretinide in high-risk women. Rationale, design and implementation

Bernardo Bonanni, Clara Varricchio, Davide Serrano, Patrick Maisonneuve, Nicole Rotmensz, Chiara Montefrancesco, Irene Feroce, Monica Barile, Simona Moroni, Lorenzo Preda, Aliana Guerrieri-Gonzaga, Umberto Veronesi
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (12_Supplement): A71.
https://doi.org/10.1158/1940-6207.PREV-10-A71
Published: 24 October 2014
View articletitled, Abstract A71: 4-HPR trial: A new phase III chemoprevention trial with fenretinide in high-risk women. Rationale, design and implementation
Journal Articles

Abstract A70: Randomized, placebo-controlled, phase III trial of low-dose tamoxifen in women with intraepithelial neoplasia

Andrea DeCensi, Matteo Puntoni, Daniela Branchi, Domenico Marra, Alessandra Argusti, Silvia Zanardi, Sara Campora, Aliana Guerrieri-Gonzaga, Harriet Johansson, Giuseppe D'Aiuto, Antonio Ponti, Cosimo D'Amico, Giuseppe Canavese, Laura Cortesi, Giovanni Giardina, Daniele Friedman, Massimo Calabrese, Beniamino Brancato, Bernardo Bonanni
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (12_Supplement): A70.
https://doi.org/10.1158/1940-6207.PREV-10-A70
Published: 24 October 2014
View articletitled, Abstract A70: Randomized, placebo-controlled, phase III trial of low-dose tamoxifen in women with intraepithelial neoplasia
Journal Articles

Abstract A47: Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: Results of a monoinstitutional observational study on 985 patients

Aliana Guerrieri-Gonzaga, Matteo Lazzeroni, Giuseppe Viale, Andrea DeCensi, Bernardo Bonanni, Edoardo Botteri, Davide Serrano, Clara Varricchio, Nicole Rotmensz, Giorgia Bollani, Serena Mora, Chiara Montefrancesco, Alberto Luini
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2011) 4 (10_Supplement): A47.
https://doi.org/10.1158/1940-6207.PREV-11-A47
Published: 23 October 2014
View articletitled, Abstract A47: Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: Results of a monoinstitutional observational study on 985 patients
Journal Articles

Abstract A56: Randomized, placebo-controlled, phase III trial of low-dose tamoxifen in women with intraepithelial neoplasia

Silvia Zanardi, Daniela Branchi, Antonio Ponti, Giorgio Cruciani, Cosimo D'Amico, Laura Cortesi, Fabio Falcini, Marcella Gulisano, Giovanni Giardina, Giuseppe Canavese, Massimo Calabrese, Andrea DeCensi, Matteo Puntoni, Sara Campora, Alessandra Argusti, Bernardo Bonanni, Aliana Guerrieri-Gonzaga, Harriet Johansson, Maria Grazia Pacquola, Giuseppe D'Aiuto
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2011) 4 (10_Supplement): A56.
https://doi.org/10.1158/1940-6207.PREV-11-A56
Published: 23 October 2014
View articletitled, Abstract A56: Randomized, placebo-controlled, phase III trial of low-dose tamoxifen in women with intraepithelial neoplasia
Journal Articles

Abstract A58: Green tea and silybin for breast cancer: A pilot presurgical study

Matteo Lazzeroni, Aliana Guerrieri Gonzaga, Andrea DeCensi, Bernardo Bonanni, Davide Serrano, Harriet Johansson, Sara Gandini, Fabio Bassi, Giancarlo Pruneri, Valentina Aristarco, Antonella Riva, Giovanna Petrangolini
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2011) 4 (10_Supplement): A58.
https://doi.org/10.1158/1940-6207.PREV-11-A58
Published: 23 October 2014
View articletitled, Abstract A58: Green tea and silybin for breast cancer: A pilot presurgical study
Journal Articles

Abstract A78: A randomized phase II presurgical trial of weekly tamoxifen versus raloxifene versus placebo in premenopausal women with breast cancer

Davide Serrano, Matteo Lazzeroni, Sara Gandini, Gianmatteo Pagani, Harriet Johansson, Giuseppe Pelosi, Serena Mora, Aliana Guerrieri Gonzaga, Andrea De Censi, Bernardo Bonanni
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (1_Supplement): A78.
https://doi.org/10.1158/1940-6207.PREV-09-A78
Published: 21 October 2014
View articletitled, Abstract A78: A randomized phase II presurgical trial of weekly tamoxifen versus raloxifene versus placebo in premenopausal women with breast cancer
Journal Articles

Abstract C49: A randomized phase II trial of low-dose aspirin versus placebo in high-risk individuals with CT screen-detected subsolid lung nodules

Aliana Guerrieri-Gonzaga, Giulia Veronesi, Pier Paolo Di Fiore, Matteo Lazzeroni, Massimo Bellomi, Eva Szabo, Lana A. Vornik, Powel H. Brown, Bernardo Bonanni
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2013) 6 (11_Supplement): C49.
https://doi.org/10.1158/1940-6215.PREV-13-C49
Published: 28 August 2014
View articletitled, Abstract C49: A randomized phase II trial of low-dose aspirin versus placebo in high-risk individuals with CT screen-detected subsolid lung nodules
Journal Articles

Abstract SS-01: Metformin effects on breast preneoplasia

Andrea DeCensi, Valentina Aristarco, Matteo Lazzeroni, Clara Varricchio, Bernardo Bonanni, Matteo Puntoni, Giancarlo Pruneri, Massimiliano Cazzaniga, Andrea Vingiani, Davide Serrano, Aliana Guerrieri-Gonzaga, Oreste Gentilini, Harriet Johansson
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2012) 5 (11_Supplement): SS-01.
https://doi.org/10.1158/1940-6207.PREV-12-SS-01
Published: 23 January 2014
View articletitled, Abstract SS-01: Metformin effects on breast preneoplasia
Journal Articles

Lapatinib Activity in Premalignant Lesions and HER-2–Positive Cancer of the Breast in a Randomized, Placebo-Controlled Presurgical Trial

Andrea DeCensi, Matteo Puntoni, Giancarlo Pruneri, Aliana Guerrieri-Gonzaga, Matteo Lazzeroni, Davide Serrano, Debora Macis, Harriet Johansson, Oriana Pala, Alberto Luini, Paolo Veronesi, Viviana Galimberti, Maria Cristina Dotti, Giuseppe Viale, Bernardo Bonanni
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2011) 4 (8): 1181–1189.
https://doi.org/10.1158/1940-6207.CAPR-10-0337
Published: 03 August 2011
View articletitled, Lapatinib Activity in Premalignant Lesions and HER-2–Positive Cancer of the Breast in a Randomized, Placebo-Controlled Presurgical Trial
Open the PDF for Lapatinib Activity in Premalignant Lesions and HER-2–Positive Cancer of the Breast in a Randomized, Placebo-Controlled Presurgical Trial in another window
Journal Articles

Randomized Phase II Trial of Inhaled Budesonide versus Placebo in High-Risk Individuals with CT Screen–Detected Lung Nodules

Giulia Veronesi, Eva Szabo, Andrea DeCensi, Aliana Guerrieri-Gonzaga, Massimo Bellomi, Davide Radice, Stefania Ferretti, Giuseppe Pelosi, Matteo Lazzeroni, Davide Serrano, Scott M. Lippman, Lorenzo Spaggiari, Angela Nardi-Pantoli, Sergio Harari, Clara Varricchio, Bernardo Bonanni
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2011) 4 (1): 34–42.
https://doi.org/10.1158/1940-6207.CAPR-10-0182
Published: 03 January 2011
View articletitled, Randomized Phase II Trial of Inhaled Budesonide versus Placebo in High-Risk Individuals with CT Screen–Detected Lung Nodules
Open the PDF for Randomized Phase II Trial of Inhaled Budesonide versus Placebo in High-Risk Individuals with CT Screen–Detected Lung Nodules in another window